BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Half-dose gadopiclenol provides equal or better breast MRI contrast than full-dose gadobutrol. Find out how it could reduce ...
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...
(RTTNews) - Altimmune (ALT) presented data from Phase 2, MRI-based body composition sub-study of pemvidutide in subjects with overweight and obesity. In the sub-study of 67 subjects from the Phase 2 ...
A chemical injected before MRI scans to help create sharper images may cause some patients to experience a potentially deadly complication in rare cases, a new study suggests. Researchers from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results